Authors: LINDEMAN KS HIRSHMAN CA KUHL JS LEVITSKY HI EMALA CW

Citation: Ks. Lindeman et al., CHRONIC OXYTOCIN PRETREATMENT INHIBITS ADENYLYL-CYCLASE ACTIVITY IN CULTURED RAT MYOMETRIAL CELLS, Biology of reproduction, 59(5), 1998, pp. 1108-1115

Authors: KUHL JS KRAJEWSKI S DURAN GE REED JC SIKIC BI

Citation: Js. Kuhl et al., SPONTANEOUS OVEREXPRESSION OF THE LONG FORM OF THE BCL-X PROTEIN IN AHIGHLY RESISTANT P388 LEUKEMIA, British Journal of Cancer, 75(2), 1997, pp. 268-274

Authors: LINDEMAN KS HIRSHMAN CA KUHL JS EMALA CW

Citation: Ks. Lindeman et al., ROLE OF PROTEIN-KINASE-C IN OXYTOCIN INHIBITION OF THE STIMULATORY PATHWAY OF ADENYLYL-CYCLASE, Anesthesiology, 87(3), 1997, pp. 914-914

Authors: DURAN GE LAU DHM LEWIS AD KUHL JS BAMMLER TK SIKIC BI

Citation: Ge. Duran et al., DIFFERENTIAL SINGLE-STRAND VERSUS DOUBLE-STRAND DNA BREAKAGE PRODUCEDBY DOXORUBICIN AND ITS MORPHOLINYL ANALOGS, Cancer chemotherapy and pharmacology, 38(3), 1996, pp. 210-216

Authors: JAFFREZOU JP CHEN G DURAN GE KUHL JS SIKIC BI

Citation: Jp. Jaffrezou et al., MUTATION-RATES AND MECHANISMS OF RESISTANCE TO ETOPOSIDE DETERMINED FROM FLUCTUATION ANALYSIS, Journal of the National Cancer Institute, 86(15), 1994, pp. 1152-1158

Authors: KUHL JS DURAN GE CHAO NJ SIKIC BI

Citation: Js. Kuhl et al., EFFECTS OF THE METHOXYMORPHOLINO DERIVATIVE OF DOXORUBICIN AND ITS BIOACTIVATED FORM VERSUS DOXORUBICIN ON HUMAN LEUKEMIA AND LYMPHOMA CELL-LINES AND NORMAL BONE-MARROW, Cancer chemotherapy and pharmacology, 33(1), 1993, pp. 10-16